Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neubauer

Showing results (531-540 of 554) with videos related to

Pageof 56
Sort By:
Molecular Cancer|July 7, 2026
Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Genome Medicine|March 19, 2020
Gene family information facilitates variant interpretation and identification of disease-associated genes in neurodevelopmental disordersDennis Lal, Patrick May, Eduardo Perez-Palma, et al.
Annals of Neurology|May 17, 2021
Mutations in HID1 Cause Syndromic Infantile Encephalopathy and HypopituitarismAnne Schänzer, Melanie T Achleitner, Dietrich Trümbach, et al.
Hemasphere|April 20, 2026
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinibMyint Myat Khine Aung, Susann Schönefeldt, Sophie Pfalz-Kraupp, et al.
Leukemia|March 27, 2004
The German competence network 'Acute and chronic leukemias'R Hehlmann, U Berger, C Aul, et al.
Molecular Cancer|May 29, 2024
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progressionTorben Redmer, Martin Raigel, Christina Sternberg, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Human Molecular Genetics|June 19, 2014
16p11.2 600 kb Duplications confer risk for typical and atypical Rolandic epilepsyEva M Reinthaler, Dennis Lal, Sebastien Lebon, et al.
Nature Immunology|April 24, 2024
JAK-STAT signaling maintains homeostasis in T cells and macrophagesNikolaus Fortelny, Matthias Farlik, Victoria Fife, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
Pageof 56

Showing results (531-540 of 554) with videos related to

Sort By:
Pageof 56
Molecular Cancer|July 7, 2026
Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Genome Medicine|March 19, 2020
Gene family information facilitates variant interpretation and identification of disease-associated genes in neurodevelopmental disordersDennis Lal, Patrick May, Eduardo Perez-Palma, et al.
Annals of Neurology|May 17, 2021
Mutations in HID1 Cause Syndromic Infantile Encephalopathy and HypopituitarismAnne Schänzer, Melanie T Achleitner, Dietrich Trümbach, et al.
Hemasphere|April 20, 2026
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinibMyint Myat Khine Aung, Susann Schönefeldt, Sophie Pfalz-Kraupp, et al.
Leukemia|March 27, 2004
The German competence network 'Acute and chronic leukemias'R Hehlmann, U Berger, C Aul, et al.
Molecular Cancer|May 29, 2024
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progressionTorben Redmer, Martin Raigel, Christina Sternberg, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Human Molecular Genetics|June 19, 2014
16p11.2 600 kb Duplications confer risk for typical and atypical Rolandic epilepsyEva M Reinthaler, Dennis Lal, Sebastien Lebon, et al.
Nature Immunology|April 24, 2024
JAK-STAT signaling maintains homeostasis in T cells and macrophagesNikolaus Fortelny, Matthias Farlik, Victoria Fife, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
Pageof 56